KRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
KORU Medical Systems, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.02+0.02 (+0.67%)
Close on Oct 19, 2026
- Market cap
- $149.52M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.03 (−25.43%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
KORU Medical Systems, Inc. grew revenue 22.4% to $45.11M over the twelve months to Jun 30, 2026. Free cash flow was $776.65K.
Revenue
$45.11M
+22.4% vs. a year earlier
Operating income
-$1.65M
TTM Q2 2026
Free cash flow
$776.65K
TTM Q2 2026
EPS, diluted
$0.00
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $149.52M
- P/E ratio
- –
- Price to sales
- 3.31
- Price to book
- 8.28
- Dividend yield
- –
- Free cash flow yield
- 0.52%
Fundamentals
- Revenue
- $45.11M
- Net income
- -$1.82M
- EPS, diluted
- $0.00
- Free cash flow
- $776.65K
- Book value per share
- $0.36
- Diluted shares
- 50M
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
$45.11M+22.4% YoY
Gross profit
$28.16M+21.0% YoY
Operating income
-$1.65M
Net income
-$1.82M
EPS, diluted
$0.00
Free cash flow
$776.65K
Reported periodTrailing twelve months